• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Antibacterial coated suture wins WHO recommendation

November 4, 2016 By Sarah Faulkner

Antibacterial coated suture wins WHO recommendationEthicon said today that its triclosan-coated suture was included in the new “Global Guidelines for the Prevention of Surgical Site Infections (SSI)” by the World Health Organization. The guidelines are the 1st global guidelines for preventing surgical site infections.

“The panel suggests the use of triclosan-coated sutures for the purpose of reducing the risk of surgical site infection (SSI), independent of the type of surgery,” the organization wrote in its guideline.

Bacterial colonization of a suture is a key risk factor for infection following surgery. The Johnson & Johnson (NYSE:JNJ) subsidiary touted its antibacterial coated sutures as the only available products coated with triclosan that can inhibit colonization by bacteria such as S. aureus, S. epidermidis, MRSA, MRSE, E. coli and K. pneumonia. Studies have shown that Ethicon Plus Sutures can inhibit bacterial colonization of the suture in vitro for 7 days or more.

“Ethicon has more than 60 years of experience in surgical sutures, and the new guidelines from WHO supports our Ethicon Plus Sutures portfolio and further reinforces our decade-long commitment to helping surgeons and their institutions address the overwhelming burden of healthcare associated infections,” franchise medical director Liza Ovington said in prepared remarks. “Ethicon is committed to shaping the future of surgery by helping address the world’s most pressing health care issues to improve and save more lives.”

“Several independent studies have found that triclosan-coated sutures reduce the risk of SSI across many types of surgery,” Professor David Leaper of the University of Huddersfield added. “Taken together with other evidence-based interventions, Ethicon Plus Sutures may help reduce hospital costs associated with infections, including longer length of stay or readmission.”

Filed Under: Business/Financial News, Drug-Device Combinations, Featured, Surgical Tagged With: Ethicon, johnsonandjohnson, World Health Organization

IN CASE YOU MISSED IT

  • Eitan Medical lands FDA clearance for infusion pump system upgrade
  • Senseonics announces $50M from stock offering
  • BD stock up on Street-beating preliminary quarterly revenue numbers
  • Locate Bio lands FDA breakthrough nod for bone infection device
  • PerkinElmer to acquire Oxford Immunotec

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Tweets by DrugDeliveryNow

Footer

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Design & Outsourcing
Medical Tubing + Extrusion

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery News
Advertise with us
About
Contact us
Privacy
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2021 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS